FEMASYS INC (FEMY:NASDAQ)
$4.19 -0.59 (-12.3431%)
Analysed FEMASYS INC (FEMY:NASDAQ) News Sources
Femasys Advances FemBloc Toward U.S. Approval with Initiation of Pivotal Trial Enrollment
10-03-2026
yahoo.com
Femasys Appoints Dr. Kenneth D. Eichenbaum to Board of Directors
18-03-2026
yahoo.com
Femasys Announces Financial Results for Year Ended December 31, 2025 and Provides Corporate Update
31-03-2026
yahoo.com
Femasys Appoints John Canning as Chief Operating Officer to Drive Operational Execution and Advance Commercial Growth
01-04-2026
yahoo.com
Femasys Drives International Growth with Israeli Market Entry for Fertility Portfolio
16-04-2026
yahoo.com
Femasys Launches FemaSeed® Complete for OB/GYNs at ACOG 2026
22-04-2026
yahoo.com
Femasys Enables OB/GYNs to Deliver First-Line Fertility Treatment with Initial Commercial Use of FemaSeed® Complete
05-05-2026
yahoo.com
Femasys Announces Financial Results for Quarter Ended March 31, 2026 and Provides Corporate Update
08-05-2026
yahoo.com
Femasys Expands Fertility Care Portfolio in Europe with CE Mark Approval for FemHSG™ Catheter
13-05-2026
yahoo.com
Innoviva Stock Is Up Just 10% This Past Year. Here's Why a Fund Bought $2.5 Million More
29-05-2026
fool.com
What is the current price of FEMASYS INC (FEMY:NASDAQ)?
The current price of FEMASYS INC (FEMY:NASDAQ) is $4.19.
FEMASYS INC (FEMY:NASDAQ) absolute price change since previous trading day?
The absolute price change of FEMASYS INC (FEMY:NASDAQ) since the previous trading day is $-0.59.
FEMASYS INC (FEMY:NASDAQ) percentage price change since previous trading day?
The percentage price change of FEMASYS INC (FEMY:NASDAQ) since the previous trading day is -12.3431%.
What is the most recent average sentiment score for FEMASYS INC (FEMY:NASDAQ)?
The most recent average sentiment score for FEMASYS INC (FEMY:NASDAQ) is 87 out of 100.
What is the most recent average sentiment for FEMASYS INC (FEMY:NASDAQ)?
The most recent sentiment for FEMASYS INC (FEMY:NASDAQ) is .
SEC-8K** Filing Available For FEMASYS INC (FEMY:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.